Statistics on Biotechnology Use  
Results by fields of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total 2019,
No. of companies carrying out R&D in Biotechnology,1.095,103,1.198,
%Companies according to biotechnology used: Genetic code,32,4,42,9,33,3,
%Companies according to biotechnology used: Functional units,38,5,54,6,39,8,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,23,2,35,1,24,2,
%Companies according to biotechnology used: Bioprocesses,48,66,9,49,6,
%Companies according to biotechnology used: Sub-cellular organisms,6,13,9,6,7,
%Companies according to biotechnology used: Bio-computing,23,9,23,9,23,9,
%Companies according to biotechnology used: Nanobiotechnology,11,1,11,8,11,2,
%Companies according to biotechnology used: Other,15,3,6,9,14,6,
Companies in which biotechnology activities are: Main and/or exclusive,616,28,644,
Companies in which biotechnology activities are: A secondary line of business,155,16,171,
Companies in which biotechnology activities are: A tool necessary for production,324,59,383,
%Company by field(s) of ultimate application of biotechnology use: Human Health,47,5,44,8,47,3,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,3,9,9,19,4,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,1,37,2,32,5,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,4,20,9,24,1,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,7,17,6,14,9,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,1,9,9,12,8,
Personnel in R&D in biotechnology (no. of persons),9.761,3.853,13.615,
Personnel in R&D in biotechnology (no. of persons): Researchers,5.539,1.898,7.436,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.223,1.956,6.178,
Personnel in R&D in biotechnology (no. of persons): women,5.266,2.373,7.639,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.968,1.127,4.095,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.298,1.246,3.544,
Personnel in R&D in biotechnology (FTE),6.635,9,2.729,4,9.365,2,
Personnel in R&D in biotechnology (FTE): Researchers,4.020,1,1.390,4,5.410,6,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.615,7,1.338,9,3.954,6,
Personnel in R&D in biotechnology (FTE): women,3.632,6,1.753,2,5.385,8,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.192,4,840,5,3.032,9,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.440,2,912,6,2.352,9,
Internal expenditure on R&D (thousands of euros),677.192,263.038,940.230,
1) By nature of the expense: Current expenses,626.080,245.733,871.813,
1.1) Remuneration to researchers,200.684,84.252,284.936,
1.2) Remuneration to technicians and assistants,87.267,60.987,148.254,
1.3) Other current expenses,338.128,100.494,438.623,
2) By nature of the expense: Capital expenses,51.113,17.304,68.417,
2.1) Land and buildings,8.402,3.361,11.763,
2.2) Equipment and instruments,26.572,13.069,39.641,
2.3) Acquisition of specific R&D software,2.155,676,2.831,
2.4) Otros productos de propiedad intelectual específicos para I+D,13.985,199,14.183,
1.1) By origin of the funds: Own funds,427.439,149.847,577.287,
1.2) By origin of the funds: From companies,104.912,37.760,142.672,
1.3) By origin of the funds: Public Administration funds,81.268,21.363,102.630,
1.4) By origin of the funds: From Universities,425,32,457,
1.5) By origin of the funds: From non profit private institutions,2.098,7.533,9.631,
1.6) By origin of the funds: Foreign funds,61.050,46.503,107.553,
Purchase of R&D services in biotechnology (thousands of euros),64.508,50.330,114.839,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,27.696,41.562,69.258,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,36.813,8.768,45.581,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,43,3,26,1,41,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,1,11,1,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,13,3,11,13,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,10,6,11,2,10,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,15,8,8,1,15,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,16,5,7,15,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,1,13,5,15,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,38,31,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,51,7,40,1,50,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,7,11,9,19,
% Companies that have requested biotechnology patents in Biotechnology,18,3,18,6,18,3,
Number of patents requested,554,89,643,
% Companies with income of an international origin related to biotechnological activities,25,2,16,1,24,4,
% Turnover representing income of an international origin related to biotechnological activities,7,1,0,9,1,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,39,7,70,9,55,7,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,60,3,29,1,44,3,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,90,9,50,7,70,3,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,4,9,41,9,23,9,
% Income of an international origin related with activities according to the classification: Operating source abroad,3,2,7,2,5,3,
% Income of an international origin related with activities according to the classification: Other,1,1,0,1,0,6,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute